Related Experiment Video

Updated: Jul 6, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

[Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors]

M Deslandres1, V Sibaud, C Chevreau

  • 1Institut Claudius Regaud, Centre de Lutte Contre le Cancer, Département d''ncologie Médicale, 20-24 rue du pont Saint Pierre 31052 Toulouse, France.

Annales De Dermatologie Et De Venereologie
|April 1, 2008
PubMed

Insights

New targeted cancer drugs, like tyrosine kinase inhibitors, cause unique skin toxicities. Understanding and managing these side effects is crucial for patient care and may indicate treatment effectiveness.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Recent advances in oncogenesis have led to targeted cancer therapies.
  • These therapies often involve tyrosine kinase inhibitors (TKIs), acting as monoclonal or small molecule drugs.
  • A significant challenge is the emergence of novel cutaneous toxicities associated with these treatments.

Purpose of the Study:

  • To describe the frequently observed skin side effects of new targeted cancer drugs.
  • To highlight the need for improved clinical management of these toxicities.
  • To explore the potential of skin side effects as surrogate markers for drug efficacy.

Main Methods:

  • Review of literature on targeted cancer therapies and their dermatological side effects.
  • Categorization of side effects based on drug class (e.g., EGFR inhibitors, multi-target TKIs).
  • Clinical observation and reporting of common cutaneous manifestations.

Main Results:

  • EGFR inhibitors commonly cause acneiform rash.
  • Multi-target TKIs induce diverse and complex skin toxicities with incompletely understood pathophysiology.
  • Observed side effects vary depending on the specific drug administered.

Conclusions:

  • Targeted cancer therapies present unique dermatological challenges requiring specialized management.
  • Effective long-term clinical management of these skin toxicities is a significant unmet medical need.
  • Cutaneous side effects may serve as valuable indicators of treatment response and drug efficacy.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...